2016-03-01 17:50:39 CET

2016-03-01 17:50:39 CET


REGULATED INFORMATION

English Finnish
Orion - Company Announcement

Orion Corporation: Transfer of 144,350 own B-shares on 1 March 2016


ORION CORPORATION      STOCK EXCHANGE RELEASE 1 MARCH 2016 at 6.50
P.M.  EET

Orion Corporation: Transfer of 144,350 own B-shares on 1 March 2016

In accordance with a decision by the Board of Directors, Orion Corporation has
on 1 March 2016 transferred altogether 144,350 Orion Corporation B-shares held
by the company as a share reward for earning periods 2013-2015 and 2015 to the
persons belonging to the Share-based Incentive Plan of the Orion Group. The
transfer is based on the authorisation by the Annual General Meeting of 19 March
2013. The price per share of the transferred shares is EUR 31.0826, which is the
volume weighted average quotation of the Orion Corporation B-share on 1 March
2016. Accordingly, the total transaction price of the transferred shares is EUR
4,486,773.31.

After the share transfer, the total number of own B-shares held by Orion
Corporation is 283 366.

Orion Corporation has informed about the Share-based Incentive Plan in stock
exchange release on 5 February 2013.


Orion Corporation

 Timo Lappalainen    Olli Huotari
 President and CEO   SVP, Corporate Functions


Contact person:
Olli Huotari, SVP, Corporate Functions, tel. +358 10 426 3054, mobile
+358 50 966 3054


Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02101 Espoo, Finland
Homepage: www.orion.fi


Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical ingredients
and diagnostic tests. The company is continuously developing new drugs and
treatment methods. The core therapy areas of Orion's pharmaceutical R&D are
central nervous system (CNS) disorders, oncology and respiratory for which Orion
develops inhaled Easyhaler(®) pulmonary drugs.

Orion's net sales in 2015 amounted to EUR 1,016 million and the Company had
about 3,400 employees. Orion's A and B shares are listed on Nasdaq Helsinki.

.


[HUG#1990579]